Verum Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$378K Sell
968
-8
-0.8% -$3.38K 0.06% 140
2026
Q1
$462K Buy
976
+4
+0.4% +$2.01K 0.09% 107
2025
Q4
$454K Buy
972
+9
+0.9% +$4.18K 0.09% 103
2025
Q3
$411K Sell
963
-11
-1% -$4.26K 0.09% 113
2025
Q2
$373K Buy
974
+25
+3% +$9.01K 0.09% 118
2025
Q1
$328K Buy
949
+8
+0.9% +$2.57K 0.09% 113
2024
Q4
$282K Buy
941
+12
+1% +$4.19K 0.08% 126
2024
Q3
$378K Buy
929
+7
+0.8% +$2.56K 0.11% 107
2024
Q2
$296K Hold
922
0.1% 115
2024
Q1
$308K Buy
922
+5
+0.5% +$1.53K 0.11% 115
2023
Q4
$248K Buy
917
+5
+0.5% +$1.24K 0.1% 122
2023
Q3
$224K Buy
+912
New +$250K 0.1% 123

Other funds holding HCA

Verum Partners's HCA Position: Q2 2026 in Review

Verum Partners reduced its HCA Healthcare (HCA) stake by 0.82% in Q2 2026, selling an estimated $3.38K and leaving 968 shares worth $378K. The position accounts for 0.06% of the portfolio, ranked #140.

Verum Partners first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $462K in Q1 2026. 269 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Verum Partners held 968 shares of HCA Healthcare worth $378K as of Q2 2026.
  • Verum Partners sold 8 HCA Healthcare shares in Q2 2026, an estimated $3.38K.
  • HCA Healthcare made up 0.06% of Verum Partners's portfolio in Q2 2026, its #140 holding.
  • Verum Partners first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Verum Partners's HCA Healthcare position peaked at $462K in Q1 2026.
  • 269 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.